These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21830545)

  • 41. The role of temozolomide in newly-diagnosed glioblastoma multiforme.
    Jenkinson MD
    Br J Neurosurg; 2008 Jun; 22(3):456. PubMed ID: 18568743
    [No Abstract]   [Full Text] [Related]  

  • 42. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic windows.
    Mol Interv; 2009 Dec; 9(6):292-3. PubMed ID: 20048133
    [No Abstract]   [Full Text] [Related]  

  • 44. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population.
    Alliot C
    Cancer; 2004 Dec; 101(12):2897-8; author reply 2898-9. PubMed ID: 15526295
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of brain tumors.
    Ashby L; LaRocca R; Ryken T
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of temozolomide in malignant brain tumours.
    Osoba D
    Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
    [No Abstract]   [Full Text] [Related]  

  • 47. Temozolomide for refractory anaplastic astrocytoma.
    Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
    [No Abstract]   [Full Text] [Related]  

  • 48. [Radiation and temozolomide therapy].
    Sonoda Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():619-22. PubMed ID: 25831834
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 50. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
    Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
    Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
    [No Abstract]   [Full Text] [Related]  

  • 51. Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
    Erridge SC; Gregor A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):194-5. PubMed ID: 16264933
    [No Abstract]   [Full Text] [Related]  

  • 52. Glioblastoma occurring after the surgical resection of a craniopharyngioma.
    Zairi F; Aboukais R; Maurage CA; Assaker R
    Br J Neurosurg; 2014 Apr; 28(2):284-6. PubMed ID: 24011139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
    Philippon M; Morange I; Barrie M; Barlier A; Taieb D; Dufour H; Conte-Devolx B; Brue T; Castinetti F
    Ann Endocrinol (Paris); 2012 Jun; 73(3):225-9. PubMed ID: 22520146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for brain tumors--a new beginning.
    DeAngelis LM
    N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
    [No Abstract]   [Full Text] [Related]  

  • 55. A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
    Rehman S; Brock C; Newlands ES
    Am J Clin Oncol; 2006 Feb; 29(1):106-7. PubMed ID: 16462515
    [No Abstract]   [Full Text] [Related]  

  • 56. Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression.
    Lolli I; Morra I; Cimmino A; Trevisan E; Rudà R; Piombino M; Campanella G; Gillio Tos A; De Marco L; Trevisan M; Fiano V; Soffietti R
    J Clin Oncol; 2013 Aug; 31(23):e394-7. PubMed ID: 23796990
    [No Abstract]   [Full Text] [Related]  

  • 57. Delirium likely caused by interaction between phenytoin and temozolomide.
    Levy M
    Psychosomatics; 2007; 48(4):359-60. PubMed ID: 17600176
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pituitary carcinoma].
    Nishioka H; Yamada S; Fukuhara N
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():212-6. PubMed ID: 21830545
    [No Abstract]   [Full Text] [Related]  

  • 59. Temozolomide: a novel treatment for pituitary carcinoma.
    Lim S; Shahinian H; Maya MM; Yong W; Heaney AP
    Lancet Oncol; 2006 Jun; 7(6):518-20. PubMed ID: 16750503
    [No Abstract]   [Full Text] [Related]  

  • 60. Temozolomide and pituitary adenoma.
    Hueng DY; Ma HI; Sytwu HK; Liu MY
    J Neurosurg; 2011 Jun; 114(6):1820: author reply 1820-1. PubMed ID: 21513431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.